Ashland Board appoints Sanat Chattopadhyay, executive vice president, Merck & Company, as new director effective November 13, 2023
November 14 2023 - 5:25PM
Ashland Inc. (NYSE: ASH) has announced the appointment of Sanat
Chattopadhyay, executive vice president of Merck & Company
(NYSE: MRK) to its Board of Directors. Chattopadhyay will serve on
the Board's Environmental, Health, Safety, and Quality and
Governance and Nominating Committees, effective November 13,
2023. Prior to Merck, Chattopadhyay held leadership positions
at Wyeth Pharmaceuticals, Aventis, Hoechst Marion Roussel and
Hoechst India.
As previously announced, Jay V. Ihlenfeld who
has served as a director since 2017, and Brendan M. Cummins, who
joined the board in 2012 have decided not to stand for re-election
at Ashland’s Annual Stockholders Meeting in January 2024. With the
addition of Chattopadhyay, Ashland temporarily increases the size
of the Board to 11 members until the next Annual Stockholders
Meeting in January 2024.
Chattopadhyay is a broadly experienced global
executive who brings strong industry leadership in manufacturing,
distribution, supply chain, and more. He has led complex operations
that span 22 countries including cutting-edge manufacturing
technology while successfully navigating the ever-changing,
globally complex, and heavily regulated industry of
biopharmaceuticals.
“I am pleased to welcome Sanat as a new director
to the Ashland Board,” said Guillermo Novo, chair and chief
executive officer, Ashland. “As we continue to execute our strategy
and increase our focus and scale in pharmaceuticals, personal care
and coatings, I am confident Sanat will provide important
perspectives for our team. And once again, I want to thank Jay and
Brendan for their dedicated service to the Board.”
To learn more, visit investor.ashland.com
About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty
ingredients company with a conscious and proactive mindset for
environment, social and governance (ESG). The company serves
customers in a wide range of consumer and industrial markets,
including architectural coatings, construction, energy, food and
beverage, nutraceuticals, personal care and pharmaceutical.
Approximately 3,800 passionate, tenacious solvers – from renowned
scientists and research chemists to talented engineers and plant
operators – thrive on developing practical, innovative and elegant
solutions to complex problems for customers in more than 100
countries. Visit ashland.com and ashland.com/ESG to learn
more.
™ Trademark, Ashland or its subsidiaries,
registered in various countries.
FOR FURTHER INFORMATION:
Investor Relations: |
Media Relations: |
Seth A. Mrozek |
Carolmarie C. Brown |
+1 (302) 594-5010 |
+1 (302) 995-3158 |
samrozek@ashland.com |
ccbrown@ashland.com |
- Ashland_announces_new_board_member_20231114
Ashland (NYSE:ASH)
Historical Stock Chart
From Jul 2024 to Aug 2024
Ashland (NYSE:ASH)
Historical Stock Chart
From Aug 2023 to Aug 2024